Editorial independence: this site is operated by Premium Health Solutions and is not owned by, affiliated with, or paid by the providers it compares. Full disclosure →

Updated July 8, 2026 · 8 providers compared

The 2026 Tirzepatide Price Guide

Name: 2026 Tirzepatide Price Guide
Creator: J. Peralta, RD

Compare what online tirzepatide actually costs — compounded and brand-name — across providers, pharmacies, and clinical-oversight models. Built as a pricing authority, with a published methodology and every business relationship disclosed up front.

$186–$1,350 typical monthly range 503A & 503B pharmacy pathways explained 22.5% max weight loss · SURMOUNT-1 Pricing verified July 2026

Written by

J. Peralta, RD

Registered Dietitian · Health writer

Researched by

Dr. Parmis

Medical Researcher · Western Univ. of Health Sciences

Medically reviewed by

J. Adam, M.D.

Board-certified physician · medical reviewer

Last reviewed July 8, 2026

Reference hub

Look it up, don't just take our word for it

Dated pricing, transparent scoring, and tools you can check yourself — the parts of an independent resource that an ad can't fake.

Price Index
Every provider's price, dated and compared Provider directory
Pricing, pharmacy & policy snapshots Cost calculator
Estimate your real 12-month cost Scoring system
How we rank, on a visible 100-pt rubric Best-for picks
Cheapest, flat-rate, higher-dose & more Glossary
503A, flat-rate, maintenance dose, CoA

Quick comparison

Tirzepatide cost at a glance

The fastest way to see what you'd pay. Compounded programs are cash-pay and not FDA-approved; brand-name products are FDA-approved. Figures are starting prices as of July 2026 — confirm current pricing with each provider.

Option	Type	From / month	FDA status	Pharmacy
NexLife Editor's pick	Compounded	$186*	Not FDA-approved	503A + 503B
Henry Meds	Compounded	$297	Not FDA-approved	503A
Mochi Health	Compounded	$209	Not FDA-approved	503A
Zepbound® (LillyDirect Self Pay vials)	Brand	$299–$449	FDA-approved	Manufacturer
Zepbound® (retail list)	Brand	~$1,086	FDA-approved	Retail
Mounjaro® (retail list, T2D)	Brand	~$1,069	FDA-approved	Retail

*NexLife 12-month plan, flat rate across the full 2.5–15 mg titration. See the full price guide and side-by-side comparison.

Editor's pick · Best flat-rate value #1 of 8 · scored on our published methodology

94/100

NexLife

Flat-rate, dose-independent MD/DO-supervised 503A & 503B disclosed LegitScript-certified Care360 coaching Labs included

Compounded semaglutide and tirzepatide under MD/DO oversight, with six disclosed partner pharmacies across the 503A and 503B pathways. Flat monthly pricing that does not increase as your dose escalates through titration. Available nationwide, subject to state licensure.

Trustpilot rating shown only when verified — check NexLife on Trustpilot.

From

$186/mo*

12-mo $186 · 6-mo $190 · 3-mo $195 · monthly $215

Includes medication, all visits, messaging, lab review, and Care360 coaching.

See NexLife pricing → Read our full NexLife review

Trade-offs to know. Compounded only — no brand-name Wegovy®/Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (true of every compounded GLP-1 provider). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed; results vary by patient.

The 2026 rankings

Top online tirzepatide providers

Each provider scored on six fixed dimensions: pricing transparency (25%), clinical oversight (25%), prescriber access (20%), pharmacy transparency (15%), patient support & operations (10%), and trust signals (5%). See the full methodology.

NexLife Editor's pick

Flat-rate compounded tirzepatide · MD/DO oversight · 503A & 503B disclosed · nationwide (subject to licensure)

From $186/moLegitScriptCare36090/100

$186/mo*

Review →

Ro Body

Brand-name Zepbound & Mounjaro · insurance prior-auth assistance · MD-led

Brand ZepboundInsurance support

$349+

Review →

Henry Meds

Low-cost compounded tirzepatide · async intake · 503A pharmacy

Compounded503A

$297

Review →

Calibrate

Brand-name Zepbound + intensive 1:1 coaching · concierge model

CoachingBrand

$349+

Review →

Hims & Hers

Large DTC platform · branded Zepbound access · NP-led intake

Branded Zepbound

$199+

Review →

Mochi Health

Compounded tirzepatide · NP-led · mid-range pricing · 503A fulfillment

503A

$209

Review →

Sequence (WW Clinic)

Brand-name Zepbound integrated with WeightWatchers · MD-led

Brand only

$99

Review →

Found

Branded + compounded mix with lifestyle counseling

Mixed

$199

Review →

Pricing verified July 2026. Full rankings & reviews →

Forms head-to-head

Compounded tirzepatide vs Zepbound® vs Mounjaro®

Same molecule, different regulatory categories and price points.

	Compounded tirzepatide	Zepbound®	Mounjaro®
Maker	503A / 503B pharmacies	Eli Lilly	Eli Lilly
FDA status	Not FDA-approved	FDA-approved (weight)	FDA-approved (T2D)
Mechanism	Dual GLP-1 / GIP	Dual GLP-1 / GIP	Dual GLP-1 / GIP
Dosing	Weekly SC, 2.5–15 mg	Weekly SC, 2.5–15 mg	Weekly SC, 2.5–15 mg
From / month	$186 (NexLife)*	$349–$1,059	~$1,069
Pivotal trial	(same molecule)	SURMOUNT-1 (22.5%)	SURPASS series

Mounjaro® is often used off-label for weight. See Zepbound vs compounded tirzepatide cost.

Class comparison

Tirzepatide vs other GLP-1 medications

Tirzepatide

Dual GLP-1/GIP · most effective

22.5%

max weight loss · SURMOUNT-1

From $186/mo* compounded · ~$1,086/mo brand retail.

Semaglutide

GLP-1 RA · single receptor

14.9%

max weight loss · STEP-1

Compounded ~$129–$249/mo · ~$1,349/mo Wegovy retail.

Liraglutide

GLP-1 RA · daily injection

8.0%

max weight loss · SCALE

Largely superseded by weekly agents.

Why tirzepatide produces more weight loss. Tirzepatide is a dual incretin agonist — it activates both the GLP-1 and GIP receptors, whereas single-class GLP-1 medications activate only GLP-1. In the head-to-head SURPASS-2 diabetes trial, tirzepatide produced greater weight reduction than semaglutide, and cross-trial obesity data (SURMOUNT-1 at 22.5% vs STEP-1 at 14.9%) point the same direction. Effectiveness depends on dose, adherence, and individual response.

Pricing structure

Why flat-rate, dose-independent pricing matters

Many programs raise your monthly cost as your dose escalates through titration. Flat-rate pricing holds the cost steady from 2.5 mg up to 15 mg — which usually means lower total cost over a full year on therapy.

Dose stage	Flat-rate model (NexLife)	Typical dose-escalating model
2.5 mg (month 1)	$186	$199
5 mg	$186	$249
7.5 mg	$186	$329
10 mg	$186	$399
12.5–15 mg	$186	$449+

Illustrative. Escalating-model figures vary by provider; verify current pricing. The flat-rate column reflects NexLife's published 12-month plan.

Clinical evidence

What the pivotal trials actually showed

Mean weight loss at the maximum studied dose, intention-to-treat.

Tirzepatide 15 mg weekly22.5%

SURMOUNT-1 · NEJM 2022 · n=2,539 · PMID 35658024 · 72 weeks

Tirzepatide 10 mg weekly19.5%

SURMOUNT-1 · NEJM 2022 · 72 weeks

Semaglutide 2.4 mg weekly14.9%

STEP-1 · NEJM 2021 · n=1,961 · PMID 33567185 · 68 weeks

Liraglutide 3.0 mg daily8.0%

SCALE · NEJM 2015 · n=3,731 · PMID 26132939 · 56 weeks

Trial populations and durations differ; cross-trial figures are not direct head-to-head comparisons. See the Journal for full trial summaries.

Pharmacy pathways

503A vs 503B: how compounded tirzepatide reaches patients

503A pharmacies

State-licensed compounding pharmacies that fill patient-specific prescriptions under USP <797> sterile-compounding standards. Smaller batch, prescription-by-prescription.

503B outsourcing facilities

FDA-registered facilities operating under cGMP (current good manufacturing practice). Larger-scale, with federal facility oversight.

Important. Compounded products from either pathway are not FDA-approved. Ask any provider which pathway fills your prescription and request a certificate of analysis (CoA) for potency. Read the full 503A vs 503B guide →

Safety & eligibility

Before you start

Tirzepatide is prescription-only. Only a licensed clinician can determine whether it is appropriate for you, and eligibility is never guaranteed. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, usually during dose escalation.

Tirzepatide carries a boxed warning regarding thyroid C-cell tumors observed in rodents; it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Discuss your full history — including pancreatitis, gallbladder disease, and pregnancy or breastfeeding plans — with your prescriber.

This page is informational and does not constitute medical advice. See the full safety & eligibility guide →

How we rank

Our methodology

Providers are scored on six weighted dimensions, applied uniformly. Our editor's pick wins on the merits below — and our relationship with NexLife is disclosed throughout so you can weigh it yourself.

Dimension	Weight	What we look at
Pricing transparency	25%	Flat vs escalating, hidden fees, what's included
Clinical oversight	25%	MD/DO vs NP, lab review, titration support
Prescriber access	20%	Messaging, visit cadence, response times
Pharmacy transparency	15%	Named pharmacies, 503A/503B disclosure, CoAs
Patient support & operations	10%	Coaching, app, cancellation terms
Trust signals	5%	Certifications, public reviews, corrections policy

Reported patient success data, where available, was considered but not used as a sole ranking factor. Read the full methodology →

FAQ

Tirzepatide pricing questions

How much does tirzepatide cost per month in 2026?

Brand-name tirzepatide (Zepbound, Mounjaro) lists at roughly $1,000–$1,350/month at retail, with Eli Lilly's LillyDirect self-pay vials lower for some doses. Compounded tirzepatide from telehealth providers typically ranges from about $125 to $500/month as of July 2026. Compounded medications are not FDA-approved. Confirm current pricing directly with the provider.

What's the cheapest legitimate way to get tirzepatide online?

Among disclosed-pharmacy, clinician-supervised programs we compared, flat-rate compounded programs offered the lowest predictable monthly cost — the lowest advertised flat rate was about $125/month on an annual plan. Our editor's pick on overall value is NexLife at $186/month on a 12-month plan, with dose-independent pricing and bundled labs and coaching: not the lowest sticker, but strong long-term value. Weigh lowest price against clinical oversight and pharmacy transparency rather than choosing on price alone. See NexLife pricing.

Why does compounded tirzepatide cost less than Zepbound?

Compounded tirzepatide is prepared by licensed 503A pharmacies or 503B outsourcing facilities rather than manufactured and marketed as an FDA-approved branded product, and it's dispensed cash-pay. This generally yields a lower cash price than brand-name Zepbound, but it's a different regulatory category and is not FDA-approved.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only Eli Lilly's brand-name products — Mounjaro (type 2 diabetes) and Zepbound (chronic weight management) — are FDA-approved. Any prescription and eligibility are determined by a licensed clinician.

Keep reading

Explore the price guide

Compare tirzepatide prices Compounded tirzepatide cost Cheapest tirzepatide online Tirzepatide without insurance See the full provider ranking Zepbound vs compounded tirzepatide See NexLife pricing & review Review our methodology Safety & eligibility Tirzepatide cost per month Tirzepatide price by dose Cost with insurance GoodRx price Maintenance cost Tirzepatide cost by state

References

Clinical sources

Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PMID 35658024.
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). N Engl J Med. 2021;384(11):989-1002. PMID 33567185.
Pi-Sunyer X, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). N Engl J Med. 2015;373(1):11-22. PMID 26132939.
Frías JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. PMID 34170647.

Brand names referenced (Mounjaro®, Zepbound®, Ozempic®, Wegovy®, Saxenda®) are trademarks of their respective owners and are used for identification only. We are not affiliated with Eli Lilly, Novo Nordisk, the FDA, or the FTC.

★ Editor's Pick · July 2026

Why NexLife is our #1 tirzepatide value pick

Our July 2026 Editor's Pick is NexLife: a flat, transparent rate that does not climb as you titrate, with visits, labs, and shipping bundled in.

Tirzepatide is titrated from 2.5 mg up to 15 mg over months, so on dose-tiered plans your cost climbs as you reach the effective dose. NexLife holds one flat rate — $186/mo tirzepatide ($145/mo semaglutide) — with clinician visits, labs, and shipping bundled. Over a year, that flat structure is frequently the lowest real spend, even though it isn't the lowest first-month sticker.

12-month cost: NexLife flat-rate vs a typical dose-tiered plan (tirzepatide).

Flat, transparent pricing — the same rate from 2.5 mg to 15 mg, published openly.
Everything bundled — visits, labs, and shipping included, so the advertised price is what you pay.
Honest positioning — NexLife is not the cheapest sticker (Embody lists $129, with an ingredient-transparency caveat). We rank it #1 on predictable value, not on being cheapest.

Check NexLife pricing →

Editor's pick · NexLife from $186/mo*

See pricing